Nicklaus Children's Hospital Selects Dicom Systems, WinguMD for Enterprise Mobile Clinical Collaboration Platform


Read Next Read Previous

Related News

New anesthesia offering helps cardiac patients recover faster and with less pain
In this news story Dr. Kristine Guleserian, renowned heart surgeon, talk about Exparel. Exparel is a new anesthesia offering that helps cardiac patients recover faster and with less pain after heart surgery. 13 year-old Jessica Garcia, born with a congenital heart defect (VSD) was the first pediatric patient to use this treatment.
Renowned Congenital Heart Surgeon, Dr. Kristine J. Guleserian, Honored with the 2018 AGBU New England District’s Global Excellence Award
Renowned congenital heart surgeon, Dr. Kristine J. Guleserian of the Nicklaus Children’s Heart Program was honored with the 2018 AGBU New England District’s Global Excellence Award for her achievements and work in congenital heart surgery and heart transplantation in Dallas, Miami and throughout the world.
Dental Health in Children with Congenital Heart Defects
Children with congenital heart defects may require special precautions before dental cleanings and treatment.

Related Press Releases

Neural-Enabled Prosthetic Hand (NEPH) System Developed at FIU restores sensation to first human subject
The NEPH system, developed at Florida International University by Ranu Jung and her Adaptive Neural Systems Laboratory team, restores a sense of touch/grasp force and hand opening by stimulating sensory nerve fibers in the residual limb with fine wires implanted inside nerves. Implantation of the device was performed by Dr. Aaron Berger and his team from Nicklaus Children’s Hospital. Berger is a hand and peripheral nerve surgeon who holds an appointment in FIU’s Department of Biomedical Engineering. 

​Personalized Medicine Initiatives Offer Hope to Acutely Ill Children at Nicklaus Children’s Hospital
Nicklaus Children’s Hospital, in collaboration with Rady Children’s Institute for Genomic Medicine and Sanford Health, has launched two genomic medicine research protocols to more effectively diagnose and treat children with unexplained illnesses.